Latest Posts › Coronavirus/COVID-19

Share:

COVID-19 Weekly Newsletter: New Vaccine EUA Expected

Updates on vaccines for young children and a massive study on the efficacy of mask-wearing in schools headline this week’s COVID-19 news....more

COVID-19 Weekly Newsletter: A Fourth Vaccine Dose?

Two prominent vaccine manufacturers submitted requests for authorization of an additional COVID-19 booster dose this week. Meanwhile, as case rates rise in Europe and China, U.S. public health officials take stock of what to...more

COVID-19 Weekly Newsletter: Masking Updates

As many mask mandates are lifted, the federal government extended its travel mask mandate by one month, and a new study illustrates the value in judicious mask use. Florida’s New Pediatric Vaccine Guidance...more

COVID-19 Weekly Newsletter: National COVID-19 Preparedness Plan

New guidance and pandemic preparedness strategies from the federal government highlight this week’s COVID-19 news. Biden Administration New Measures To Combat COVID-19...more

COVID-19 Weekly Newsletter: New Guidance on Measuring Severity Anticipated

As vaccination rates drop to an all-time low in the United States, the CDC is preparing new guidance on measuring the severity of outbreaks in our communities. Meanwhile, a study on the impact of hospitalization on the mental...more

COVID-19 Weekly Newsletter: International News

In this edition of the COVID-19 weekly newsletter, we take a look at a number of international COVID-19 news items. U.S. Doses Turned Away Due to Logistical Hurdles - The U.S. has donated and shipped 437 million doses...more

COVID-19 Weekly Newsletter: Time To Lift Mandates?

As the number of cases throughout the nation drops, states are starting to lift mask mandates and COVID-19 restrictions. However, some leaders have cautioned against easing practices that mitigate spread. Meanwhile, recent...more

COVID-19 Weekly Newsletter: Pediatric COVID-19 Patients

A number of recent studies have sought to identify commonalities among COVID-19 patients under the age of 18 who have required hospitalization. In addition, many new studies have worked to measure the impact of the COVID-19...more

COVID-19 Weekly Newsletter: “Mix-and-Match” Vaccinations Safe, Effective

This week, early findings of an NIH-backed study were released — showing that a combination of doses from any authorized vaccines is safe and effective. Meanwhile, the Department of Labor shifts focus to a traditional...more

COVID-19 Weekly Newsletter: Medical Staff Shortages, Tests in the Mail

This week, the Biden administration formed a new task force to plan for future variants and made COVID-19 tests available for free through the mail, while medical leaders continue to sound the alarm about increasingly dire...more

COVID-19 Weekly Newsletter: Masks, Tests and the Supreme Court

The Biden administration signaled new plans to make tests and masks available for free, in the same week that the Supreme Court blocked the federal government from enforcing its “vaccine or test” mandate for private...more

COVID-19 Weekly Newsletter: CDC Expands Booster Recommendation

As 2022 gets underway, public health agencies have been busy updating guidelines and working to expand vaccine access as health care providers and researchers contend with the now-dominant Omicron variant. ‘Flurona’ Case...more

COVID-19 Weekly Newsletter: Booster Shots and the Omicron Variant

In our final newsletter of 2021, we share updates on the federal government’s latest vaccine recommendations, the spread of the Omicron variant, and what the preliminary findings tell us about the need for booster shots to...more

COVID-19 Weekly Newsletter: The Latest on the Omicron Variant

As the holiday season continues, the Omicron variant has prompted an exceptional level of research activity and information-sharing. The early evidence on the Omicron variant is a mixture of encouraging news and more...more

COVID-19 Weekly Newsletter: What Do We Know About the Omicron Variant?

The Omicron variant has prompted considerable concern and uncertainty in the COVID-19 response, as public health leaders continue to advocate for vaccines and booster shots and researchers make progress in the development of...more

COVID-19 Weekly Newsletter: Booster Shots Get FDA, CDC Greenlight

Major developments in vaccine authorizations and mandates continue in the U.S., while the surge in Europe has prompted one country to implement a lockdown — and also declare a national vaccine mandate. mRNA COVID-19...more

COVID-19 Weekly Newsletter: Cases Rise for First Time in Two Months, Global Vaccine Tracker Unveiled

A global vaccine tracker is unveiled as cases are on the rise for the first time in two months. With herd immunity unlikely at this point, researchers are developing the next generation of COVID-19 vaccines. COVID Cases...more

COVID-19 Weekly Newsletter: Vaccine Approved for Children, OSHA Vaccination Mandate

Efforts to continue to promote and expand access to COVID-19 vaccines reached major milestones this week, as the holiday season draws near. OSHA Vaccination Mandate - In early September, President Biden released a...more

COVID-19 Weekly Newsletter: Average Case Rates Drop From Delta Wave’s Heights

This week’s newsletter details the latest developments in the process of approving COVID-19 vaccines for children ages 5-11, a vaccine that produced promising clinical results, and new studies revealing insights about...more

COVID-19 Weekly Newsletter: Additional Booster Shots Recommended as FDA Prepares to Evaluate Vaccines for Younger Children

Booster Shot Endorsements - Last week, the U.S. Food and Drug Administration (FDA) advisory committee endorsed one of the mRNA COVID-19 vaccines and the single-dose vaccine to be used as a booster shot. This week, FDA...more

COVID-19 Weekly Newsletter: A Trio of Potential EUAs

In the coming weeks, the Food and Drug Administration (FDA) will be contemplating three noteworthy emergency use authorizations (EUA). Meanwhile, public health authorities continue to work to assuage public skepticism toward...more

COVID-19 Weekly Newsletter: A Pill To Treat COVID-19?

A promising new COVID-19 treatment grabbed headlines this week, along with new updates on one mRNA vaccine manufacturer’s path to potentially seeking Food and Drug Administration (FDA) approval on vaccines for children...more

COVID-19 Weekly Newsletter: Domestic and International Vaccine News

Clinical trials and public health recommendations relating to booster vaccines and potential vaccines for children under the age of 12 continue to be front and center in the United States’ domestic COVID-19 response....more

COVID-19 Weekly Newsletter: Updates on Vaccines for Children and Potential Authorization for Booster Shots

Amid continued spread of the Delta variant and sobering new studies about the toll COVID-19 has exacted on medical staff, vaccine manufacturers and public health leaders continue to seek solutions — including efforts to...more

COVID-19 Weekly Newsletter: Biden Announces New Pandemic Plan

On September 9, President Biden announced a new six-pronged plan to address COVID-19, which includes bold steps aimed at increasing vaccination rates. Biden’s Path Out of the Pandemic Plan - On Thursday, President...more

71 Results
 / 
View per page
Page: of 3

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide